Catalyst
Slingshot members are tracking this event:
Sorrento Announces Positive Data from a Combined Phase 2 & 3 Clinical Study of STI-004, an Anti-IgE Biosimilar Antibody
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SRNE | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 16, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Sti-004, Anti-ige Biosimilar Antibody, Combined Phase 2 & 3 Clinical Study
